LHC Group (NASDAQ:LHCG) has received a consensus recommendation of “Buy” from the ten brokerages that are presently covering the company, Marketbeat reports. Ten analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have covered the stock in the last year is $66.89.

Several equities research analysts have recently issued reports on the company. Stephens set a $69.00 price objective on LHC Group and gave the company a “buy” rating in a research note on Saturday, May 6th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $69.00 price objective on shares of LHC Group in a research note on Tuesday, July 18th. Zacks Investment Research raised LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price objective for the company in a research note on Saturday, August 5th. BidaskClub raised LHC Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Finally, Benchmark Co. raised their price objective on LHC Group from $63.00 to $72.00 and gave the company a “buy” rating in a research note on Thursday, June 8th.

In related news, COO Donald Dwayne Stelly sold 3,181 shares of the firm’s stock in a transaction that occurred on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total transaction of $206,669.57. Following the completion of the sale, the chief operating officer now directly owns 114,235 shares of the company’s stock, valued at approximately $7,421,847.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Coliseum Capital Management, L sold 77,524 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $61.73, for a total value of $4,785,556.52. The disclosure for this sale can be found here. Insiders have sold a total of 292,894 shares of company stock valued at $18,394,109 over the last three months. 14.80% of the stock is owned by corporate insiders.

Several large investors have recently modified their holdings of the company. Alps Advisors Inc. raised its stake in shares of LHC Group by 0.3% in the second quarter. Alps Advisors Inc. now owns 9,449 shares of the health services provider’s stock worth $641,000 after buying an additional 24 shares in the last quarter. Eqis Capital Management Inc. raised its stake in shares of LHC Group by 0.8% in the first quarter. Eqis Capital Management Inc. now owns 6,486 shares of the health services provider’s stock worth $350,000 after buying an additional 53 shares during the period. Federated Investors Inc. PA raised its stake in shares of LHC Group by 4.2% in the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock worth $110,000 after buying an additional 66 shares during the period. Louisiana State Employees Retirement System raised its stake in shares of LHC Group by 1.7% in the first quarter. Louisiana State Employees Retirement System now owns 6,100 shares of the health services provider’s stock worth $329,000 after buying an additional 100 shares during the period. Finally, Arizona State Retirement System raised its stake in shares of LHC Group by 1.3% in the second quarter. Arizona State Retirement System now owns 7,818 shares of the health services provider’s stock worth $531,000 after buying an additional 100 shares during the period. 85.88% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/09/01/analysts-set-lhc-group-lhcg-target-price-at-66-89.html.

Shares of LHC Group (NASDAQ:LHCG) traded down 1.10% during mid-day trading on Tuesday, reaching $64.53. The company’s stock had a trading volume of 23,341 shares. The company has a market cap of $1.18 billion, a PE ratio of 28.55 and a beta of 0.77. The company has a 50-day moving average price of $62.77 and a 200 day moving average price of $58.44. LHC Group has a 52-week low of $32.04 and a 52-week high of $69.35.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.09. The business had revenue of $260.20 million during the quarter, compared to analyst estimates of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company’s revenue for the quarter was up 15.1% on a year-over-year basis. During the same period last year, the company earned $0.52 EPS. Equities analysts expect that LHC Group will post $2.39 earnings per share for the current year.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Stock Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related stocks with our FREE daily email newsletter.